Status:
NOT_YET_RECRUITING
Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease
Lead Sponsor:
West China Hospital
Conditions:
Secondary Hyperparathyroidism Due to Renal Causes
End Stage Renal Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data ...
Detailed Description
Data were retrospectively collected from an established database of patients who underwent surgery for renal secondary hyperparathyroidism (SHPT). Extracted information included demographic and clinic...
Eligibility Criteria
Inclusion
- Age ≥18 years； Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.
Exclusion
- Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels \>300 pg/mL within the first week after surgery.
- Patients with missing postoperative quality of life assessment data.
Key Trial Info
Start Date :
September 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07151664
Start Date
September 5 2025
End Date
December 20 2026
Last Update
September 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.